Back to Trades
Yablonka Uri
EVP & Chief Business OfficerDirectorCIK 0001608814
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Yablonka Uri, EVP & Chief Business Officer, Director, has disclosed $0 in transactions — all concentrated in BRAINSTORM CELL THERAPEUTICS INC. (BCLI). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| May 29 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Yablonka Uri | EVP & Chief Business Officer, Director | Grant | $0 |
1 filing